The Promising Results from Lumito’s First International Pilot Study Were Presented at Liverpool Pathology 2023
The results from Lumito's first international pilot study show that it is possible to detect the deposition of immunoglobulin and complement in renal tissue using Lumito's technology. The result confirms the expectations that the study was based around and demonstrates that Lumito's technology has the potential to be established in renal diagnostics. In May, Lumito's […]
Lumito attends the 19th European Congress on Digital Pathology in Budapest
Lumito is attending the 19th European Congress on Digital Pathology in Budapest, June 14th – 17th, 2023. Lumito's Project Manager, Krzysztof Krawczyk, is present with the company's CTO, Andreas Johansson. Krzysztof also gives a poster presentation. See attached picture from the first day. For further information, please contact: Mattias Lundin, CEO LumitoE-mail: ml@lumito.sePh: +46 76 868 […]
Lumito launches new website
Lumito has now launched a new website. The website is designed to better reflect Lumito's ongoing commercialisation phase, with a special focus on the SCIZYS product ahead of the upcoming product launch. Visit our new website here! For further information, please contact: Mattias Lundin, CEO LumitoE-mail: ml@lumito.sePh: +46 76 868 45 09 Lumito Lumito specialises in medical […]
EMC testing at an external company in Germany
Yesterday, EMC testing (electromagnetic compatibility testing) of Lumito's product, SCIZYS, began with an external independent testing company in Germany to obtain an external assessment that ensures the product meets all relevant requirements. The company has prepared well with Optronic Partner pr for the independent EMC test and is now ready. The EMC testing is a […]
Presentation of results from a pilot study using Lumito’s imaging technology
In December 2022, the scientific article "Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer" was published in Cancer Immunology Research. The lead author of the published article, Tommy Lidström, was at Lumito in mid-February to present the results as part of Lumito's first exclusive presentation held for potential end customers […]
Exhibiting at EACR Congress in Torino and Nordic Oncology Forum in Stockholm in June 2023
Continuing the company’s marketing work towards commercialization by igniting interest and awareness in potential customers and collaborators, Lumito will be exhibiting at the European Association for Cancer Research (EACR) 2023 in Torino, Italy 12-15 of June, as well as Nordic Oncology Forum in Stockholm 26-27 of June. “We look forward to showcasing our product and […]
Live demonstration of Lumito’s scanner confirmed problem-solving capabilities
We finally got to show our product, SCIZYS by Lumito, during a live demonstration where tissue images were scanned in Lumito's laboratory under the supervision of around ten researchers and pathologists from the Malmö/Lund area. The visitors saw the added value of our product and confirmed the problem that Lumito could potentially solve. Tommy Lidström, […]
Planning for the next strategic step after Europe – the US tissue diagnostics research market
Following the launch of SCIZYS, Lumito's solution for research laboratories operating in tissue diagnostics in Sweden, followed by the Nordic countries and the rest of Europe, the next strategic step is now being planned, a launch in the world's largest research market, the US. This growing market is estimated to be worth approximately USD 733 […]
Lumito on BioStock’s list of the 10 strongest life science stocks 2022
BioStock has listed this year's ten strongest Swedish life science stocks and taken a closer look at some companies to see what's behind the share price increases. Lumito is ranked third on the list: "Lumito rises ahead of market launch High up on this year's winners list we also find diagnostics company Lumito, […]
Reflections from the Digital Pathology & AI Congress. Lumito – New kid in town
Lumito participated with a booth of our own at the Digital Pathology & AI Congress in London in early December. The congress was attended by over 440 delegates and was held at a conference hotel at Heathrow. The delegates, primarily from Western Europe, were specifically interested in the digitalization of pathology with both research and […]